Results 81 to 90 of about 272,924 (242)

Acute coronary syndromes [PDF]

open access: yesCanadian Medical Association Journal, 2004
Anthony J J, McClelland   +3 more
openaire   +5 more sources

Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome.

open access: yes, 2015
AIMS This study evaluated associations between plasma T-cadherin levels and severity of atherosclerotic disease. METHODS AND RESULTS Three hundred and ninety patients undergoing coronary angiography were divided into three groups based on ...
Schoenenberger, Andreas   +5 more
core   +1 more source

Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using National Veterans Health Administration, Medicare, and National Death Index data (2006–2020).
Tate M. Johnson   +13 more
wiley   +1 more source

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)

open access: yesTrials, 2009
Background The prevalence of depression in patients with acute coronary syndrome, i.e. myocardial infarction and unstable angina, is higher than in the general population. The prevalence of anxiety is higher as well.
Hansen Jørgen   +4 more
doaj   +1 more source

Perivascular fat attenuation index measured by coronary computed tomography angiography as a tool for assessment of ischaemia-causing lesions: a case report

open access: yesBMC Cardiovascular Disorders, 2023
Background It can be difficult to diagnose coronary artery disease in patients with acute coronary syndrome if coronary angiography does not identify stenosis. Coronary inflammation, which can contribute to the pathogenesis of coronary artery disease and
Shuichi Okamoto   +5 more
doaj   +1 more source

Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Interstitial lung disease (ILD) is an important extra‐articular manifestation of rheumatoid arthritis (RA) associated with high mortality and morbidity. Lung ultrasonography (LUS) has recently emerged as a possible screening tool. We assessed the role of LUS in monitoring radiologic progression and the development of new interstitial lung ...
Marie Vermant   +15 more
wiley   +1 more source

Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome.

open access: yes, 2009
Objectives Myeloperoxidase, an abundant leucocyte enzyme, is elevated in culprit lesions that have ruptured in patients with sudden cardiac injury. Multiple lines of evidence suggest an association between myeloperoxidase and inflammation and acute ...
Gururajan, P.   +6 more
core   +1 more source

PERAN PERAWAT DALAM IDENTIFIKASI DINI DAN PENATALAKSANAAN PADA ACUTE CORONARY SYNDROME

open access: yesJurnal Ilmiah Kesehatan, 2018
The role of nurses in the early identification and treatment on Acute Coronary Syndrome. Introduction : Acute Coronary Syndrome ( ACS ) is an emergency in the coronary arteries .
Nur Ainiyah
doaj   +1 more source

Platelet quiescence in patients with acute coronary syndrome undergoing coronary artery bypass graft surgery

open access: yes, 2021
BACKGROUND: The optimal antiplatelet strategy for patients with acute coronary syndromes who require coronary artery bypass surgery remains unclear. While a more potent antiplatelet regimen will predispose to perioperative bleeding, it is hypothesized ...
Chong, AY   +17 more
core   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy